Recently, LAMP2 has been considered a valuable biomarker of tumor acidosis, and its overexpression has been correlated with breast cancer progression to malignant stages, as it allows the adaptation and survival of cancer cells in low-pH tumor microenvironments. This evidence concerns the gene LAMP2 and breast cancer.